Evidence map›Paper›PMID 20493457›Full record

ArticleAmerican journal of human genetics2010

Dominant-negative mutations in alpha-II spectrin cause West syndrome with severe cerebral hypomyelination, spastic quadriplegia, and developmental delay.

Hirotomo Saitsu, Jun Tohyama, Tatsuro Kumada, Kiyoshi Egawa, Keisuke Hamada, Ippei Okada, Takeshi Mizuguchi, Hitoshi Osaka, Rie Miyata, Tomonori Furukawa and 17 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 152 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. A De Novo Splicing Mutation ofInternational journal of molecular sciences · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. De Novo and Dominantly Inherited SPTAN1 Mutations Cause Spastic Paraplegia and Cerebellar Ataxia.Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Heterozygous variants in SPTBN1 cause intellectual disability and autism.American journal of medical genetics. Part A · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 14 institutions in 1 country.

Hirotomo SaitsuDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan. hsaitsu@yokohama-cu.ac.jp
Jun Tohyama
Tatsuro Kumada
Kiyoshi Egawa
Keisuke Hamada
Ippei Okada
Takeshi Mizuguchi
Hitoshi Osaka
Rie Miyata
Tomonori Furukawa
Kazuhiro Haginoya
Hideki Hoshino
Tomohide Goto
Yasuo Hachiya
Takanori Yamagata
Shinji Saitoh
Toshiro Nagai
Kiyomi Nishiyama
Akira Nishimura
Noriko Miyake
Masayuki Komada
Kenji Hayashi
Syu-Ichi Hirai
Kazuhiro Ogata
Mitsuhiro Kato
Atsuo Fukuda
Naomichi Matsumoto
Yokohama City University · JPHamamatsu University School of Medicine · JPDokkyo Medical University Saitama Medical Center · JPHokkaido University · JPJichi Medical University · JPKanagawa Children's Medical Center · JPNational Center For Child Health and Development · JPNishi Niigata Chuo National Hospital · JPSendai Shakai Hoken Hospital · JPTohoku University · JPTokyo Institute of Technology · JPTokyo Metropolitan Children's Medical Center · JPTokyo Metropolitan Neurological Hospital · JPYamagata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A de novo 9q33.3-q34.11 microdeletion involving STXBP1 has been found in one of four individuals (group A) with early-onset West syndrome, severe hypomyelination, poor visual attention, and developmental delay. Although haploinsufficiency of STXBP1 was involved in early infantile epileptic encephalopathy in a previous different cohort study (group B), no mutations of STXBP1 were found in two of the remaining three subjects of group A (one was unavailable). We assumed that another gene within the deletion might contribute to the phenotype of group A. SPTAN1 encoding alpha-II spectrin, which is essential for proper myelination in zebrafish, turned out to be deleted. In two subjects, an in-frame 3 bp deletion and a 6 bp duplication in SPTAN1 were found at the initial nucleation site of the alpha/beta spectrin heterodimer. SPTAN1 was further screened in six unrelated individuals with WS and hypomyelination, but no mutations were found. Recombinant mutant (mut) and wild-type (WT) alpha-II spectrin could assemble heterodimers with beta-II spectrin, but alpha-II (mut)/beta-II spectrin heterodimers were thermolabile compared with the alpha-II (WT)/beta-II heterodimers. Transient expression in mouse cortical neurons revealed aggregation of alpha-II (mut)/beta-II and alpha-II (mut)/beta-III spectrin heterodimers, which was also observed in lymphoblastoid cells from two subjects with in-frame mutations. Clustering of ankyrinG and voltage-gated sodium channels at axon initial segment (AIS) was disturbed in relation to the aggregates, together with an elevated action potential threshold. These findings suggest that pathological aggregation of alpha/beta spectrin heterodimers and abnormal AIS integrity resulting from SPTAN1 mutations were involved in pathogenesis of infantile epilepsy.

Indexed as

Amino Acid SequenceAnimalsBrainCells, CulturedDevelopmental DisabilitiesHumansInfantMiceMolecular Sequence DataMyelin SheathPhenotypeQuadriplegiaSpasms, InfantileSpectrinTransfectionSpectrinSPTBN1 protein, human

Identifiers

PMID20493457
PMCPMC3032058
OpenAlexW2016194769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.